Literature DB >> 16101811

Harvesting peripheral blood progenitor cells from healthy donors with a short course of recombinant human granulocyte-colony-stimulating factor.

M Martino1, F Morabito, I Callea, A Pontari, G Irrera, G Pucci, A Dattola, G Messina, G Console, P Iacopino.   

Abstract

A short-course administration of non-glycosylated granulocyte-colony-stimulating factor (G-CSF) was investigated in 68 healthy donors (HDs) in order to collect > or = 4 x 10(6) CD34+ cells per kilogram of recipient's body weight. G-CSF was given at 10 microg/kg per day administered in two divided doses for 3 days. Leukapheresis was scheduled on day 4, 12 h after the last dose of G-CSF. A median of 35.6 circulating CD34+ cells microL(-1) (range, 3.1-185) was found on the day of leukapheresis. This allowed a median collection of CD34+ cells of 4.2 x 10(6) per kilogram of recipient's weight (range, 1.0-17.4). One single procedure was sufficient to reach the target level of CD34+ cells in 36 (53%) of 68 donors; significant correlations were found between the number of CD34+ cells collected on day 4 and the patient's sex, body-weight and volume of blood processed. A retrospective analysis was made with a historical group of HDs collected on day 5. The day 5 schedule allowed a more consistent achievement of the target cell dose with one leukapheresis (P = 0.005) and resulted in the initial collection of a significantly larger number of CD34+ cells (P = 0.006).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16101811     DOI: 10.1111/j.0958-7578.2005.00595.x

Source DB:  PubMed          Journal:  Transfus Med        ISSN: 0958-7578            Impact factor:   2.019


  2 in total

1.  A single apheresis procedure in the donor may be enough to complete an allograft using the "Mexican method" of non-ablative allografting.

Authors:  Guillermo J Ruiz-Delgado; Karla I Gutiérrez-Riveroll; César H Gutiérrez-Aguirre; David Gómez-Almaguer; Renee Eyzaguirre-Zapata; Manuel Priesca-Marin; Martha L González-Carrillo; Guillermo J Ruiz-Argüelles
Journal:  Blood Transfus       Date:  2009-04       Impact factor: 3.443

Review 2.  G-CSF-primed BM for allogeneic SCT: revisited.

Authors:  I Pessach; I Resnick; A Shimoni; A Nagler
Journal:  Bone Marrow Transplant       Date:  2015-03-02       Impact factor: 5.483

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.